AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE
Authors: KYRLE PA MANNHALTER C BEGUIN S STUMPFLEN A HIRSCHL M WELTERMANN A STAIN M BRENNER B SPEISER W PABINGER I LECHNER K EICHINGER S
Citation: Pa. Kyrle et al., CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE, Arteriosclerosis, thrombosis, and vascular biology, 18(8), 1998, pp. 1287-1291
A NOVEL IMMUNOASSAY FOR THE QUANTIFICATION OF HUMAN TISSUE FACTOR-BINDING TO ACTIVATED FACTOR-VII
Authors: WELTERMANN A EICHINGER S KYRLE PA
Citation: A. Weltermann et al., A NOVEL IMMUNOASSAY FOR THE QUANTIFICATION OF HUMAN TISSUE FACTOR-BINDING TO ACTIVATED FACTOR-VII, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 177-182
FAMILIAL LUPUS ANTICOAGULANT - A CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: HELLAN M KUHNEL E SPEISER W LECHNER K EICHINGER S
Citation: M. Hellan et al., FAMILIAL LUPUS ANTICOAGULANT - A CASE-REPORT AND REVIEW OF THE LITERATURE, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 195-200
HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS
Authors: WELTERMANN A PABINGER I GEISSLER K JAGER U GISSLINGER H KNOBL P EICHINGER S KYRLE PA VALENT P SPEISER W SCHWARZINGER I MANNHALTER C LECHNER K
Citation: A. Weltermann et al., HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS, Leukemia, 12(8), 1998, pp. 1182-1186
HYPERHOMOCYSTEINEMIA IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM
Authors: EICHINGER S STUMPFLEN A HIRSCHL M BIALONCZYK C HERKNER K STAIN M SCHNEIDER B PABINGER I LECHNER K KYRLE PA
Citation: S. Eichinger et al., HYPERHOMOCYSTEINEMIA IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 80(4), 1998, pp. 566-569
DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)
Authors: WELTERMANN A MITTERBAUER GJ MITTERBAUER M HATTEY E SPEISER W GISSLINGER H KNOBL P EICHINGER S
Citation: A. Weltermann et al., DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT), Wiener Klinische Wochenschrift, 110(2), 1998, pp. 53-57
INTRAHEPATIC SPLENIC TISSUE IN A PATIENT WITH RECURRENT IDIOPATHIC THROMBOCYTOPENIC PURPURA
Authors: WEKERLE T EICHINGER S MAIER A WRBA F MOSCHL P
Citation: T. Wekerle et al., INTRAHEPATIC SPLENIC TISSUE IN A PATIENT WITH RECURRENT IDIOPATHIC THROMBOCYTOPENIC PURPURA, Surgery, 123(5), 1998, pp. 596-599
RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR INCREASES LEVELS OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: GEISSLER K KABRNA E STENGG S SCHWARZINGER I KNOBL P VALENT P EICHINGER S BARGE A LECHNER K
Citation: K. Geissler et al., RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR INCREASES LEVELS OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(2), 1998, pp. 535-543
SELF-ALIGNED PACKAGING OF AN 8X8 INGAASP-INP SPACE SWITCH
Authors: WENGER G SCHIENLE M BELLERMANN J ACKLIN B MULLER J EICHINGER S MULLER G
Citation: G. Wenger et al., SELF-ALIGNED PACKAGING OF AN 8X8 INGAASP-INP SPACE SWITCH, IEEE journal of selected topics in quantum electronics, 3(6), 1997, pp. 1445-1456
HYPERHOMOCYSTEINEMIA (H-HC) IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM (VTE) IN MALE-PATIENTS
Authors: EICHINGER S STUMPFLEN A HIRSCHL M BIALONCZYK C PABINGER I HERKNER K SCHNEIDER B LECHNER K KYRLE PA
Citation: S. Eichinger et al., HYPERHOMOCYSTEINEMIA (H-HC) IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM (VTE) IN MALE-PATIENTS, Thrombosis and haemostasis, 1997, pp. 745-745
CLINICAL-SIGNIFICANCE AND COURSE OF LUPUS ANTICOAGULANTS IN CHILDREN
Authors: MALE C KAPIOTIS S EICHINGER S KYRLE PA LECHNER K
Citation: C. Male et al., CLINICAL-SIGNIFICANCE AND COURSE OF LUPUS ANTICOAGULANTS IN CHILDREN, Thrombosis and haemostasis, 1997, pp. 1621-1621
QUANTIFICATION OF HUMAN TISSUE FACTOR (TF) BINDING TO RECOMBINANT FACTOR VIIA (RVIIA)
Authors: WELTERMANN A KYRLE PA EICHINGER S
Citation: A. Weltermann et al., QUANTIFICATION OF HUMAN TISSUE FACTOR (TF) BINDING TO RECOMBINANT FACTOR VIIA (RVIIA), Thrombosis and haemostasis, 1997, pp. 1649-1649
HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS WITH HYPERHOMOCYSTEINEMIA (H-HC)
Authors: KYRLE PA EICHINGER S STUMPFLEN A HIRSCHL M BIALONCZYK C HERKNER K PABINGER I SPEISER W SCHNEIDER B LECHNER K
Citation: Pa. Kyrle et al., HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS WITH HYPERHOMOCYSTEINEMIA (H-HC), Thrombosis and haemostasis, 1997, pp. 2181-2181
NO EVIDENCE FOR AN INCREASE OF THE RISK OF VENOUS THROMBOSIS IN PATIENTS WITH FACTOR-V-LEIDEN BY THE HOMOZYGOUS MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE
Authors: RINTELEN C PABINGER I LECHNER K EICHINGER S KYRLE PA MANNHALTER C
Citation: C. Rintelen et al., NO EVIDENCE FOR AN INCREASE OF THE RISK OF VENOUS THROMBOSIS IN PATIENTS WITH FACTOR-V-LEIDEN BY THE HOMOZYGOUS MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE, Thrombosis and haemostasis, 1997, pp. 2329-2329
MARKED COAGULATION ACTIVATION DURING PREGNANCY WITHOUT EVIDENCE OF VENOUS THROMBOEMBOLISM (VTE)
Authors: EICHINGER S BRENNER B PHILIPP K PUTZ M SCHUCHTER K BAUER K KITTL E KAIDER A WELTERMANN A LECHNER K KYRLE PA
Citation: S. Eichinger et al., MARKED COAGULATION ACTIVATION DURING PREGNANCY WITHOUT EVIDENCE OF VENOUS THROMBOEMBOLISM (VTE), Thrombosis and haemostasis, 1997, pp. 2475-2475
HIGH PREVALENCE OF STILLBIRTHS IN WOMEN HOMOZYGOUS FOR FACTOR-V-LEIDEN MUTATION
Authors: RINTELEN C SCHARRER I KLINKE S MANNHALTER C EICHINGER S KYRLE PA LECHNER K PABINGER I
Citation: C. Rintelen et al., HIGH PREVALENCE OF STILLBIRTHS IN WOMEN HOMOZYGOUS FOR FACTOR-V-LEIDEN MUTATION, Thrombosis and haemostasis, 1997, pp. 3103-3103
LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM
Authors: KYRLE PA STUMPFLEN A HIRSCHL M BIALONCZYK C HERKNER K SPEISER W WELTERMANN A KAIDER A PABINGER I LECHNER K EICHINGER S
Citation: Pa. Kyrle et al., LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 78(5), 1997, pp. 1327-1331
PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM
Authors: KYRLE PA EICHINGER S PABINGER I STUMPFLEN A HIRSCHL M BIALONCZYK C SCHNEIDER B MANNHALTER C MELICHART M TRAXLER G WELTERMANN A SPEISER W LECHNER K
Citation: Pa. Kyrle et al., PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 77(5), 1997, pp. 829-833
THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT FACTOR-V-LEIDEN
Authors: EICHINGER S PABINGER I STUMPFLEN A HIRSCHL M BIALONCZYK C SCHNEIDER B MANNHALTER C MINAR E LECHNER K KYRLE PA
Citation: S. Eichinger et al., THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT FACTOR-V-LEIDEN, Thrombosis and haemostasis, 77(4), 1997, pp. 624-628
INHIBITION RATHER THAN ENHANCEMENT OF HEMOSTATIC SYSTEM ACTIVATION DURING INITIATION OF ORAL ANTICOAGULANT TREATMENT
Authors: KYRLE PA BROCKMEIER J WELTERMANN A EICHINGER S SPEISER W LECHNER K EICHLER HG
Citation: Pa. Kyrle et al., INHIBITION RATHER THAN ENHANCEMENT OF HEMOSTATIC SYSTEM ACTIVATION DURING INITIATION OF ORAL ANTICOAGULANT TREATMENT, Thrombosis and haemostasis, 77(4), 1997, pp. 685-689
EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS
Authors: RUZICKA K KAPIOTIS S QUEHENBERGER P HANDLER S HORNYKEWYCZ S MICHITSCH A HUBER K CLEMENS D SUSAN M PABINGER I EICHINGER S JILMA B SPEISER W
Citation: K. Ruzicka et al., EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS, Thrombosis research, 87(5), 1997, pp. 431-440
RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR AUGMENTS MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: GEISSLER K KABRNA E STENGG S SCHWARZINGER I KNOBL P VALENT P EICHINGER S BARGE A LECHNER K
Citation: K. Geissler et al., RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR AUGMENTS MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 431-431
LUPUS ANTICOAGULANT AND THROMBOEMBOLISM - EVALUATION OF FIBRINOGEN, NATURAL INHIBITORS AND MOLECULAR MARKERS OF THROMBOSIS
Authors: GSCHWANDTNER ME EICHINGER S HUTTER D KORNINGER L LECHNER K PANZER S PABINGER I
Citation: Me. Gschwandtner et al., LUPUS ANTICOAGULANT AND THROMBOEMBOLISM - EVALUATION OF FIBRINOGEN, NATURAL INHIBITORS AND MOLECULAR MARKERS OF THROMBOSIS, Blood coagulation & fibrinolysis, 7(3), 1996, pp. 325-330
A 1X8 INP INGAASP OPTICAL MATRIX SWITCH WITH LOW INSERTION LOSS AND HIGH CROSSTALK SUPPRESSION/
Authors: SCHIENLE M WENGER G EICHINGER S MULLER J STOLL L MULLER G
Citation: M. Schienle et al., A 1X8 INP INGAASP OPTICAL MATRIX SWITCH WITH LOW INSERTION LOSS AND HIGH CROSSTALK SUPPRESSION/, Journal of lightwave technology, 14(5), 1996, pp. 822-826
A COMPLETELY PACKAGED STRICTLY NONBLOCKING 8X8 OPTICAL MATRIX SWITCH ON INP INGAASP/
Authors: WENGER G SCHIENLE M BELLERMANN J HEINBACH M EICHINGER S MULLER J ACKLIN B STOLL L MULLER G
Citation: G. Wenger et al., A COMPLETELY PACKAGED STRICTLY NONBLOCKING 8X8 OPTICAL MATRIX SWITCH ON INP INGAASP/, Journal of lightwave technology, 14(10), 1996, pp. 2332-2337
Risultati: 1-25 | 26-47